MICE MICE Target Mechanism CM38 – Napa Valley P J Smith on behalf of the MICE target team.
Tranasgenic Mice
-
Upload
anjanakaveri -
Category
Documents
-
view
224 -
download
0
Transcript of Tranasgenic Mice
-
8/11/2019 Tranasgenic Mice
1/16
Using DNA Technology to Produce
Transgenic Animals
-
8/11/2019 Tranasgenic Mice
2/16
-
8/11/2019 Tranasgenic Mice
3/16
Transgenic Animals: A Focuson Transgenic Mice Studies
http://www.hku.hk/biochem/tgcentre/transcentre.html
http://www.hku.hk/biochem/tgcentre/transcentre.htmlhttp://www.hku.hk/biochem/tgcentre/transcentre.html -
8/11/2019 Tranasgenic Mice
4/16
I. IntroductionTransgenic animals:
Animals which have been genetically engineered tocontain one or more genes from an exogenous source.
Transgenes are integrated into the genome.
Transgenes can be transmitted through the germline to progeny.
First transgenic animal produced = Founder Animal
-
8/11/2019 Tranasgenic Mice
5/16
II. Introduction of foreign genesinto intact organisms
Procedure is basically the same regardless ofwhich animal is involved.
Integration usually occurs prior to DNAreplication in the fertilized oocyte.
Majority of transgenic animals carry the gene in all oftheir cells, including the germ cells. Transmissionto next generation requires germline integration.
Some integration events occur subsequent to DNAreplication giving rise to mosaic animals which may or
may not contain the transgene in its germline.
-
8/11/2019 Tranasgenic Mice
6/16
III. Procedure for Producing
Transgenic Mice
Three different breeding pairs of mice arerequired.
-
8/11/2019 Tranasgenic Mice
7/16
First Breeding Pair: Fertile male + superovulated female
Fertile male = stud (changed regularly to ensure performance)
Superovulated female = immature female induced tosuperovulate
Pregnant mares serum (=FSH) on day 1 Human Chorionic Gonadotropin (=LH) on day 3
Mated on day 3
Fertilized oocytes microinjected on day 4 with foreign DNAconstruct.
Microinjected oocytes are transferred to the oviducts ofsurrogate mothers at end of day 4.
-
8/11/2019 Tranasgenic Mice
8/16
Second breeding pair: Sterile male + surrogate mother
Sterile male produced through vasectomy Surrogate mother must mate to be suitable recipient of
injected eggs Mated on day 3 Microinjected oocytes from first breeding pair are
transferred to oviducts on day 4 Embryos implant in uterine wall and are born 19 days later.
Southern blotting techniques confirm presence and copynumber of transgenes.
-
8/11/2019 Tranasgenic Mice
9/16
Third breeding pair: Foster parents
Fertile male + female mated to give birth on sameday surrogate mother
Serves as foster parent if caesarian section isrequired for surrogate mother
-
8/11/2019 Tranasgenic Mice
10/16
http://www.itba.mi.cnr .it/human_g...transgenic.html
http://www.altavista.com/r?ck_sm=614f5e6f&ref=20096&r=http%3A%2F%2Fwww.altavista.com%2Fsites%2Fsearch%2Fmm_resultframe%3Fq%3Ddrug%2Bcompanies%2Band%2Btransgenic%2Bplants%26type%3DIMG%26url%3Dhttp%253A%252F%252Fwww.itba.mi.cnr.it%252Fhuman_genome%252Ftransgenic.html%26title%3Dgene3.gif%26isrc%3Dhttp%253A%252F%252Fthumb-2.image.altavista.com%252Fimage%252F100726944%26src%3Dhttp%253A%252F%252Fwww.itba.mi.cnr.it%252Fimages%252Fgene3.gif%26stq%3D60%26stype%3Dsimagehttp://www.altavista.com/r?ck_sm=614f5e6f&ref=20096&r=http%3A%2F%2Fwww.altavista.com%2Fsites%2Fsearch%2Fmm_resultframe%3Fq%3Ddrug%2Bcompanies%2Band%2Btransgenic%2Bplants%26type%3DIMG%26url%3Dhttp%253A%252F%252Fwww.itba.mi.cnr.it%252Fhuman_genome%252Ftransgenic.html%26title%3Dgene3.gif%26isrc%3Dhttp%253A%252F%252Fthumb-2.image.altavista.com%252Fimage%252F100726944%26src%3Dhttp%253A%252F%252Fwww.itba.mi.cnr.it%252Fimages%252Fgene3.gif%26stq%3D60%26stype%3Dsimagehttp://www.altavista.com/r?ck_sm=614f5e6f&ref=20096&r=http%3A%2F%2Fwww.altavista.com%2Fsites%2Fsearch%2Fmm_resultframe%3Fq%3Ddrug%2Bcompanies%2Band%2Btransgenic%2Bplants%26type%3DIMG%26url%3Dhttp%253A%252F%252Fwww.itba.mi.cnr.it%252Fhuman_genome%252Ftransgenic.html%26title%3Dgene3.gif%26isrc%3Dhttp%253A%252F%252Fthumb-2.image.altavista.com%252Fimage%252F100726944%26src%3Dhttp%253A%252F%252Fwww.itba.mi.cnr.it%252Fimages%252Fgene3.gif%26stq%3D60%26stype%3Dsimagehttp://www.altavista.com/r?ck_sm=614f5e6f&ref=20096&r=http%3A%2F%2Fwww.altavista.com%2Fsites%2Fsearch%2Fmm_resultframe%3Fq%3Ddrug%2Bcompanies%2Band%2Btransgenic%2Bplants%26type%3DIMG%26url%3Dhttp%253A%252F%252Fwww.itba.mi.cnr.it%252Fhuman_genome%252Ftransgenic.html%26title%3Dgene3.gif%26isrc%3Dhttp%253A%252F%252Fthumb-2.image.altavista.com%252Fimage%252F100726944%26src%3Dhttp%253A%252F%252Fwww.itba.mi.cnr.it%252Fimages%252Fgene3.gif%26stq%3D60%26stype%3Dsimagehttp://www.altavista.com/r?ck_sm=614f5e6f&ref=20096&r=http%3A%2F%2Fwww.altavista.com%2Fsites%2Fsearch%2Fmm_resultframe%3Fq%3Ddrug%2Bcompanies%2Band%2Btransgenic%2Bplants%26type%3DIMG%26url%3Dhttp%253A%252F%252Fwww.itba.mi.cnr.it%252Fhuman_genome%252Ftransgenic.html%26title%3Dgene3.gif%26isrc%3Dhttp%253A%252F%252Fthumb-2.image.altavista.com%252Fimage%252F100726944%26src%3Dhttp%253A%252F%252Fwww.itba.mi.cnr.it%252Fimages%252Fgene3.gif%26stq%3D60%26stype%3Dsimagehttp://www.altavista.com/r?ck_sm=614f5e6f&ref=20096&r=http%3A%2F%2Fwww.altavista.com%2Fsites%2Fsearch%2Fmm_resultframe%3Fq%3Ddrug%2Bcompanies%2Band%2Btransgenic%2Bplants%26type%3DIMG%26url%3Dhttp%253A%252F%252Fwww.itba.mi.cnr.it%252Fhuman_genome%252Ftransgenic.html%26title%3Dgene3.gif%26isrc%3Dhttp%253A%252F%252Fthumb-2.image.altavista.com%252Fimage%252F100726944%26src%3Dhttp%253A%252F%252Fwww.itba.mi.cnr.it%252Fimages%252Fgene3.gif%26stq%3D60%26stype%3Dsimage -
8/11/2019 Tranasgenic Mice
11/16
-
8/11/2019 Tranasgenic Mice
12/16
V. Gene Expression inTransgenic Mice
In order to discriminate the products of theinjected gene from those of an endogenouscounterpart, the injected gene must be marked insome way. Mini-genes where exons are deleted of cDNA where
introns are absent. Modification by insertion/deletion/mutagenesis of a few
nucleotides (e.g. the gain or loss of a restrictionendonuclease site). Hybrid genes where foreign epitopes are expressed on
transgenic products.
-
8/11/2019 Tranasgenic Mice
13/16
VI. Tissue-Specific GeneExpression
Generally, if a tissue-specific gene is expressed at all, thenit is expressed appropriately, despite the fact that it hasintegrated at a different chromosomal location.
-
8/11/2019 Tranasgenic Mice
14/16
VII. Examples of StudiesUtilizing Transgenic Mice
Pharm animals (transgenic livestock)
Bioreactors whose cells have been engineered tosynthesize marketable proteins
DNA constructs contain desired gene and appropriateregulatory sequences (tissue-specific promoters)
More economical than producing desired proteins incell culture
-
8/11/2019 Tranasgenic Mice
15/16
Naked human Hb from pigsHuman lactoferrin in
cows milk Alpha-1-antitrypsin insheepHGH in mouse urine(uroplakin promoters)Human antibodies in mice(H and L chain tgenics hybridomas)
CfTCR in goatsTissue plasminogenactivator (TPA) in goatsHuman antithrombin III ingoatsMalaria antigens in goats(vaccine)Alpha-glucosidase inrabbits (Pompes disease
-
8/11/2019 Tranasgenic Mice
16/16
VIII. Transgenic Pigs for theProduction of Organs for
TransplantationPig organs are rejected acutely due to the presenceof human antibodies to pig antigens.
Once human antibodies are bound to pig organs,human complement is activated and triggers thecomplement cascade and organ destruction.
Transgenic pigs with complement inhibitors have been produced and are gaining feasibility as asource of xenogeneic organs for transplantation.